[Chemoradiation therapy and immunotherapy for pancreatic cancer].
Egawa
Shinichi
S
Department of Gastroenterological Surgery, Tohoku University Graduate School of Medicine.
Motoi
Fuyuhiko
F
Fukuyama
Shoji
S
Sunamura
Makoto
M
Unno
Michiaki
M
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003713:Dendritic Cells / Q000276:immunology; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007430:Intraoperative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine